Organizers
CISSN
Coordinator:
Filippo Drago –
BIOMETEC, University of Catania, (Italy)
Prof. Filippo Drago is an Italian pharmacologist, neurologist and psychiatrist. He is Full Professor of Pharmacology at the University of Catania, Italy. He graduated in Medicine and Surgery in 1978 from the University of Catania and a PhD in Pharmacology in 1982 from the University of Utrecht, The Netherlands, in collaboration with Prof. David de Wied. He has held various positions in international pharmacological societies, as President of the Federation of European Pharmacological Societies (EPHAR) and member of the nomination committee of the International Union of Basic and Clinical Pharmacology (IUPHAR). In September 2015, Prof. Filippo Drago was appointed president of the Neuropsychopharmacology Section of IUPHAR. He holds numerous patents in the field of pharmacology and has published around 500 articles in peer-reviewed journals. He has been awarded with several scientific awards, such as the gold medal as a distinguished pharmacologist. In the last decade he has also worked in the fields of Pharmacovigilance and Pharmacoeconomics. He was a member of the Scientific Council of the Italian Medicines Agency, Italian Medicines Agency (AIFA), from 2004 to 2009 and was a member of the AIFA Board for Pricing and Reimbursement from 2012 to 2015. He was Director of the International Doctorate in Neuropharmacology (2002-2013) and is director of the Master in Drug Regulatory Affairs of the University of Catania. The main research interests of Prof. Filippo Drago are in the fields of Ocular Pharmacology and Neuropsychopharmacology.
CISSN
2022 Scientific Director:
Michelangelo Mancuso - University of Pisa & AOUP, (Italy)
Professor Mancuso has more than 20-years experience on neurology and on treating patients with various neurological diseases, and more than 15-years training experience on EMG/NCS exams and carotid and transcranial Doppler evaluation. Professor Mancuso is the head of the Centre of Neurogenetics and expertise for mitochondrial diseases and rare diseases at the Neurological Clinic of the University Hospital of Pisa (Orphanet Center EUGTIT247621). Mancuso is also a staff-member of the neuromuscular disorder group and physician expertise of the Laboratory of Liquor (CSF) analysis and molecular biology of neurological diseases at the same Institute. Scientific and research activity of Professor Michelangelo Mancuso has mainly been conducted in the field of mitochondrial, neurogenetics (including neuromuscular diseases), neurodegenerative diseases and stroke. Sectors of interest are epidemiological and clinical-molecular correlation studies in muscular pathologies, investigations of genotype-phenotype interrelationships and physiopathology of metabolic alterations in mitochondrial diseases, assessment of biological and genetic markers in cerebellar ataxia, HSP, amyotrophic lateral sclerosis, Alzheimer's disease, and other genetic neuromuscular and neurodegenerative disorders. As a whole result, his research activity has been presented in national and international congresses and published for a number of more than 280 full papers on peer-rewieved Life Science/Current Contents cited scientific journals (available on request). According to Scopus, Dr Mancuso’s articles have more than 14000 citations, and the H-Index is 48. He has edited in 2019 the Springer Book “Diagnosis and Management of Mitochondrial Disorders” (ISBN 978-3-030-05516-5). Professor Mancuso is actively involved in multiple projects mainly focusing on mitochondrial diseases and mitochondrial dysfunction in neurodegeneration. He is the Coordinator of the Italian Network of Mitochondrial diseases, Granted by Telethon in 2009, and is also member of the International Consortium of Mitochondrial diseases experts for the development of the International Database for Mitochondrial diseases. Professor Mancuso has coordinated clinical trials on mitochondrial diseases (Tetracycline, published in Acta Neurological Scandinavia journal in 2011; cysteine donor supplementation, published in the Journal of Neurology in 2010), has been invited to published several reviews focusing on mitochondrial therapy (i.e. Drugs and mitochondrial diseases: 40 queries and answers, Expert Opin Pharmacother. 2012), and he has coordinated the international working group on Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults (PMID 29074296). Grants selection: Telethon GUP09004, Telethon GSP09001, RF-2016-02361495 and EJPRD2019 project GENOMIT. Mancuso is the Coordinator of the Neurogenetics Group of the Italian Society of Neurology, co-chair of the EAN Coordinating Panel on Rare Neurological Diseases and past-chair of the Neurogenetics Panel of the European Academy of Neurology. The Neurological Institute where Prof Mancuso is working is member of the ERN NMD (where I’m the vice representative of the HCP), and of the ERN RND (where I am the HCP representative). Recently, Dr Mancuso has been also nominated co-chair of the mitochondrial working group of the ERN NMD, and chair of the inter-ERN mitochondrial working group.. Finally, Professor Mancuso acts as peer- reviewer for numerous scientific journals (including Lancet Neurology, New England Journal of Medicine, Human Molecular Genetics, Neuromuscular disorders, Journal of Neurology, Annals of Neurology, and more) and for several National Research Programme (including the French National Research Agency, Polish National Agency, and more).
|
